Vimarsana
Biggest News Aggregation in the World

Page 5 - Nasdaq Huma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Huma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Huma Today - Breaking & Trending Today

Humacyte (NASDAQ:HUMA) Raised to Neutral at Piper Sandler - Vimarsana News

Humacyte (NASDAQ:HUMA) Raised to Neutral at Piper Sandler

Piper Sandler upgraded shares of Humacyte (NASDAQ:HUMA – Free Report) from an underweight rating to a neutral rating in a research note issued to investors on Monday, Marketbeat reports. The brokerage currently has $3.50 price objective on the stock, up from their previous price objective of $2.75. Separately, Cantor Fitzgerald initiated coverage on Humacyte in […]

Comparing Kymera Therapeutics (NASDAQ:KYMR) & Humacyte (NASDAQ:HUMA) - Vimarsana News

Comparing Kymera Therapeutics (NASDAQ:KYMR) & Humacyte (NASDAQ:HUMA)

Humacyte (NASDAQ:HUMA – Get Free Report) and Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation. Profitability This table compares Humacyte and Kymera Therapeutics’ […]

Source: wkrb13.com
Humacyte (NASDAQ:HUMA) Research Coverage Started at Cantor Fitzgerald - Vimarsana News

Humacyte (NASDAQ:HUMA) Research Coverage Started at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Humacyte (NASDAQ:HUMA – Get Rating) in a report published on Thursday, The Fly reports. The brokerage issued an overweight rating and a $6.00 target price on the stock. Separately, Benchmark reissued a buy rating and issued a $16.00 price objective on shares of Humacyte in a research report […]

Source: wkrb13.com
Humacyte, Inc. (NASDAQ:HUMA) CEO Sells $1,560,000.00 in Stock - Vimarsana News

Humacyte, Inc. (NASDAQ:HUMA) CEO Sells $1,560,000.00 in Stock

Humacyte, Inc. (NASDAQ:HUMA – Get Rating) CEO Laura E. Niklason sold 500,000 shares of the business’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $3.12, for a total transaction of $1,560,000.00. Following the transaction, the chief executive officer now directly owns 9,990,736 shares in the company, […]

Humacyte, Inc. (NASDAQ:HUMA) Sees Large Increase in Short Interest - Vimarsana News

Humacyte, Inc. (NASDAQ:HUMA) Sees Large Increase in Short Interest

Humacyte, Inc. (NASDAQ:HUMA – Get Rating) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 5,520,000 shares, an increase of 5.7% from the April 30th total of 5,220,000 shares. Based on an average daily volume of 262,600 shares, the days-to-cover ratio is presently […]